menu
    • menu

    Company profile for Ivy Brain Tumor Center

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ivy Brain Tumor Center at the Barrow Neurological Institute is a nonprofit translational science initiative established by a $50 million investment from the Ben & Catherine Ivy Foundation in partnership with the Barrow Neurological Foundation. This represents the largest single research grant in the history of brain tumor research, worldwide. Our research program is singularly focused on discovering new therapies for brain tu...
    Ivy Brain Tumor Center at the Barrow Neurological Institute is a nonprofit translational science initiative established by a $50 million investment from the Ben & Catherine Ivy Foundation in partnership with the Barrow Neurological Foundation. This represents the largest single research grant in the history of brain tumor research, worldwide. Our research program is singularly focused on discovering new therapies for brain tumor patients through a broad portfolio of pharmacodynamic- and pharmacokinetic-driven clinical trials, combining industry-partnered drug development with the nation’s largest operative brain tumor volume.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ivy Brain Tumor CenterUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2910 North Third Avenue Phoenix, Arizona 85013
    Telephone
    Telephone
    (602) 406-6489
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ivybraintumorcenter.org/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ivy-brain-tumor-center/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/IvyBrainTumCtr

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ivy Brain Tumor Center Announces Initial Results of Pamiparib Newly-Diagnosed
    Ivy Brain Tumor Center Announces Initial Results of Pamiparib Newly-Diagnosed

    10 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/10/2513564/0/en/Ivy-Brain-Tumor-Center-Announces-Initial-Results-of-Pamiparib-in-Newly-Diagnosed-and-Recurrent-Glioblastoma-at-the-European-Society-for-Medical-Oncology-ESMO-2022-Congress.html

    GLOBENEWSWIRE
    10 Sep 2022
    Share Share
    Ivy Brain Tumor Center Collaborates with GSK on New Phase 0
    Ivy Brain Tumor Center Collaborates with GSK on New Phase 0

    02 Nov 2021

    // PRESS RELEASE

    https://www.ivybraintumorcenter.org/about/newsroom/news/ivy-brain-tumor-center-collaborates-with-gsk-on-new-phase-0-clinical-trial-to-evaluate-niraparib-in-patients-with-brain-cancer/

    PRESS RELEASE
    02 Nov 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search